Skip to main content
. 2016 May 17;114(12):1405–1411. doi: 10.1038/bjc.2016.130

Figure 2.

Figure 2

Haematoxylin-eosin staining and 2SC immunohistochemical staining of four uterine leiomyomas from two HLRCC patients (original magnification, × 200). Tumours deficient for FH and without a MED12 mutation (top panel; patient B3 tumour m3 and patient E1 tumour m7) display clear positive 2SC staining, whereas tumours harbouring a MED12 mutation and not displaying biallelic FH inactivation (bottom panel; patient B3 tumour m2 and patient E1 tumour m10) are negative.